Why is Divi's Lab. falling/rising?

As of 19-Aug, Divis Laboratories Ltd is experiencing a decline in its stock price, currently at 6,082.80, which reflects a decrease of 49.2 points or 0.8%. The stock has underperformed its sector today by 0.67%, and while it is higher than its 5-day moving averages, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 28.88% compared to the 5-day average. Over the past month, the stock has seen a significant decline of 9.41%, contrasting with its strong performance over the past year, where it has returned 30.11%, significantly outperforming the benchmark Sensex, which has only returned 1.52%.
In the broader market context, while Divis Laboratories has shown resilience with a year-to-date performance of -0.28% compared to the Sensex's +4.49%, its recent struggles may be attributed to a combination of falling investor interest and underperformance in the short term. Despite high management efficiency, a low debt-to-equity ratio, and positive financial results over the last four quarters, the stock's current liquidity and declining delivery volumes suggest a cautious sentiment among investors. The stock's ability to generate returns that beat the market over the past year indicates potential strength, but the recent trends may be causing concern among investors, leading to the current price decline.